Latest Breaking News On - Study of company - Page 1 : comparemela.com

First-in-Human Study of Company's CD137/PD-L1 Tetravalent Bispecific Antibody Expands into Tumor Specific IndicationsCAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Dec. 07, 2021, taking place online only

United kingdomUnited statesComunidad autonoma de catalunaHelen shikUniversitario fundaciLindsey trickettElena garraldaLouis kayitalireStudy of companyTherapeutics incVp investor relations communicationsShik communicationsSecurities exchangeVall dhebron institute of oncologyFirst in human studyBispecific antibody expands